Overview

Study on Avatrombopag for the Promotion of Platelet Engraftment After Allo-HSCT

Status:
Not yet recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of avatrombopag in the treatment of thrombocytopenia after Allo-HSCT.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University